|
1) Katzenstein AL, Fiorelli RF. Nonspecific inter-stitial pneumonia/fibrosis. Histologic features and clinical significance. Am J Surg Pathol. 1994; 18: 136-47
|
|
|
|
2) Katzenstein AL, Myers JL. Idiopathic pulmonary fibrosis. Clinical relevance of pathologic classification. Am J Respir Crit Care Med. 1998; 157: 1301-15
|
|
|
|
|
|
3) American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International Consensus statement. Am J Respir Crit Care Med. 2000; 161: 646-64
|
|
|
|
|
|
4) Bjoraker JA, Ryu JH, Edwin MK, et al. Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 1998; 157: 199-203
|
|
|
|
|
|
5) Nagai S, Kitaichi M, Itoh H, et al. Idiopathic nonspecific interstitial pneumonia/fibrosis: comparison with idiopathic pulmonary fibrosis and BOOP. Eur Respir J. 1998; 12: 1010-9
|
|
|
|
|
6) American Thoracic Society/European Respiratory Society international multidisciplinary consensus classification of idiopathic interstitial pneumo-nias: general principles and recommendations. Am J Respir Crit Care Med. 2002; 165: 277-304
|
|
|
|
|
|
7) 日本呼吸器学会びまん性肺疾患, 診断・治療ガイドライン作成委員会, 編. In: 特発性間質性肺炎診断と治療の手引き. 東京: 南江堂; 2004
|
|
|
|
|
|
8) Nicholson AG, Wells AU. Nonspecific interstitial pneumonia nobody said it's perfect. Am J Respir Crit Care Med. 2001; 164: 1553-4
|
|
|
|
|
|
9) Park JH, Kim DS, Park IN, et al. Prognosis of fibrotic interstitial pneumonia-idiopathic versus collagen vascular disease-related subtypes. Am J Respir Crit Care Med. 2007; 175: 705-11
|
|
|
|
|
|
10) Kinder BW, Collard HR, Koth L, et al. Idiopathic nonspecific interstitial pneumonia: Lung manifestation of undifferentiated connective tissue disease？ Am J Respir Crit Care Med. 2007; 176: 691-7
|
|
|
|
|
|
11) King TE Jr. Clinical advances in the diagnosis and therapy of the interstitial lung diseases. Am J Respir Crit Care Med. 2005; 172: 268-79
|
|
|
|
|
|
12) Kim DS, Collard HR, King TE Jr. Classification and natural history of the idiopathic interstitial pneumonias. Proc Am Thorac Soc. 2006; 3: 285-92
|
|
|
|
|
|
13) Martines FJ. Idiopathic interstitial pneumonias. Usual interstitial pneumonia versus nonspecific interstitial pneumonia. Proc Am Thorac Soc. 2006; 3: 81-95
|
|
|
|
|
|
14) du Bois RM, King TE, Jr. Challenges in pulmonary fibrosis・5: The NSIP/UIP debate. Thorax. 2007; 62: 1008-12
|
|
|
|
|
|
15) Maher TM, Wells AU, Laurent GJ. Idiopathic pulmonary fibrosis: multiple causes and multiple mechanisms？ Eur Respir J. 2007; 30: 835-9
|
|
|
|
|
|
16) Nicholson AG, Addis BJ, Bharucha H, et al. Inter-observer variation between pathologists in diffuse parenchymal lung disease. Thorax. 2004; 59: 500-5
|
|
|
|
|
|
17) 井上義一, 蛇澤 晶, 山鳥一郎, 他. 特発性間質性肺炎の外科的肺生検組織パターン一致率に関する検討. 厚生労働科学研究費補助金 難治性疾患克服研究事業 びまん性肺疾患に関する調査研究班 平成18年度研究報告書. 2007. p. 82-5
|
|
|
|
|
|
18) Flaherty KR, Travis WD, Colby TV, et al. Histopathologic variability in usual and non-specific interstitial pneumonias. Am J Respir Crit Care Med. 2001; 164: 1722-7
|
|
|
|
|
|
19) Johkoh T, Muller NL, Cartier Y, et al. Idiopathic interstitial pneumonias: diagnostic accuracy of thin-section CT in 129 patients. Radiology. 1999; 211: 555-60
|
|
|
|
|
|
20) Aziz ZA, Wells AU, Hansell DM, et al. HRCT diagnosis of diffuse parenchymal lung disease: interobserver variation. Thorax. 2004; 59: 506-11
|
|
|
|
|
|
21) Hartman TE, Swensen SJ, Hansell DM, et al. Nonspecific interstitial pneumonia: variable appearance at high-resolution chest CT. Radiology. 2000; 217: 701-5
|
|
|
|
|
|
22) MacDonald SLS, Rubens MB, Hansell DM, et al. Nonspecific interstitial pneumonia and usual interstitial pnuemonia: comparative appearances at and diagnostic accuracy of thin-section CT. Radiology. 2001; 221: 600-5
|
|
|
|
|
|
23) Johkoh T, Muller NL, Colby TV, et al. Nonspecific interstitial pneumonia: Correlation between thin-section CT findings and pathologic subgroups in 55 patients. Radiology. 2002; 225: 199-204
|
|
|
|
|
|
24) Sumikawa H, Johkoh T, Ichikado K, et al. Usual interstitial pneumonia and chronic idiopathic interstitial pneumonia: analysis of CT appearance in 92 patients. Radiology. 2006; 241: 258-66
|
|
|
|
|
|
25) Egan JJ, Martinez FJ, Wells AU, et al. Lung function estimates in idiopathic pulmonary fibrosis: the potential for a simple classification. Thorax. 2005; 60: 270-3
|
|
|
|
|
|
26) Collard HR, King TE, Bartelson BB, et al. Changes in clinical and physiologic variables predict survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2003; 168: 538-42
|
|
|
|
|
|
27) Latsi PI, du Bois RM, Nicholson AG, et al. Fibrotic idiopathic interstitial pneumonia: the prognostic value of longitudinal functional trends. Am J Respir Crit Care Med. 2003; 168: 531-7
|
|
|
|
|
|
28) Jegal U, Kim DS, Shim TS, et al. Physiology is a stronger predictor of survival than pathology in fibrotic interstitial pneumonia. Am J Respir Crit Care Med. 2005; 171: 639-44
|
|
|
|
|
|
29) Lama VN, Flaherty KR, Toews GB, et al. Prognostic value of desaturation during a 6-minute walk test in idiopathic interstitial pneumonia. Am J Respir Crit Care Med. 2003; 168: 1084-90
|
|
|
|
|
|
30) Welker L, Jorres RA, Costabel U, et al. Predictive value of BAL cell differentials in the diagnosis of interstitial lung diseases. Eur Respir J. 2004; 24: 1000-6
|
|
|
|
|
|
31) Veeraraghavan S, Latsi PI, Wells AU, et al. BAL findings inidiopathic nonspecific interstitial pneumonia and usual interstitial pneumonia. Eur Respir J. 2003; 22: 239-44
|
|
|
|
|
|
32) Ryu YJ, Chung MP, Han J, et al. Bronchoalveolar lavage in fibrotic idiopathic interstitial pneumonias. Respir Med. 2007; 101: 655-60
|
|
|
|
|
|
33) 吉村邦彦. 遺伝子発現からみたIPFとNSIP. 分子呼吸器病学. 2007; 11: 324-8
|
|
|
|
|
|
34) Selman M, Pardo A, Barrera L, et al. Gene expression profiles distinguish idiopathic pulmonary fibrosis from hypersensitivity pneumonitis. Am J Respir Crit Care Med. 2006; 173: 188-98
|
|
|
|
|
|
35) Yang IV, Burch LH, Steele MP, et al. Gene expression profiling of familial and sporadic interstitial pneumonia. Am J Respir Crit Care Med. 2007; 175: 45-54
|
|
|
|
|
|
36) Rosas IO, Kaminski N. When it comes to genes-IPF or NSIP, familial or sporadic-they're all the same. Am J Respir Crit Care Med. 2007; 175: 5-6
|
|
|
|
|
|
37) Kondoh Y, Taniguchi H, Yokoi T, et al. Cyclophosphamide and low-dose prednisolone in idiopathic pulmonary fibrosis and fibrosing nonspecific interstitial pneumonia. Eur Respir J. 2005; 25: 528-33
|
|
|
|
|
|
38) 田中良哉. SLE患者における多剤抵抗性遺伝子発現と病態との関連性, およびその制御に関する研究. 厚生科学研究費補助金 特定疾患対策研究事業 自己免疫疾患の病院・病態解析と新たな治療法の開発に関する研究 平成12年度総括・分担研究報告書. 2001. p. 69-72
|
|
|
|
|
|
39) 谷口博之, 近藤康博, 木村智樹, 他. fibrotic NSIPに対するステロイドパルス療法およびシクロスポリン＋少量ステロイド療法の多面的評価. 厚生労働科学研究費補助金 難治性疾患克服研究事業 特発性肺線維症の予後改善を目指したサイクロスポリン＋ステロイド療法ならびにNアセチルシステイン吸入療法に関する臨床研究に関する調査研究班 平成18年度研究報告書. 2007. p. 73-9
|
|
|
|
|
|
40) Collard HR, Moore BB, Flaherty KR, et al. Acute exacerbations of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2007; 176: 636-43
|
|
|
|
|
|
41) Maher TM, Wells AU, Laurent GJ. Idiopathic pulmonary fibrosis: multiple causes and multiple mechanisms？ Eur Respir J. 2007; 30: 835-9
|
|
|
|
|